Advertisement

Is Living Kidney Donation the Answer to the Economic Problem of End-Stage Renal Disease?

      Summary

      The escalating number and cost of treating patients with end-stage renal disease is a considerable economic concern for health care systems and societies globally. Compared with dialysis, kidney transplantation leads to improved patient survival and quality of life, as well as cost savings to the health payer. Despite efforts to increase kidney transplantation, the gap between supply and demand continues to grow. In this article we explore the economic consideration of both living and deceased transplantation. Although living kidney donation has several advantages from an economic perspective, efforts to increase both deceased and living donation are required. Strategies to increase kidney donation are underfunded, and even costly strategies are likely to lead to net health care savings. However, demonstration of efficacy of these strategies is required to ensure efficient use of resources.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Seminars in Nephrology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • U.S. Renal Data Systems
        USRDS 2008 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States.
        National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda2008
        • Nissenson A.R.
        • Rettig R.A.
        Medicare's end-stage renal disease program: current status and future prospects.
        Health Aff (Millwood). 1999; 18: 161-179
        • Neil N.
        • Walker D.R.
        • Sesso R.
        • Blackburn J.C.
        • Tschosik E.A.
        • Sciaraffia V.
        • et al.
        Gaining efficiencies: resources and demand for dialysis around the globe.
        Value Health. 2009; 12: 73-79
        • Beohar N.
        • Erdogan A.K.
        • Lee D.C.
        • Sabbah H.N.
        • Kern M.J.
        • Teerlink J.
        • et al.
        Acute heart failure syndromes and coronary perfusion.
        J Am Coll Cardiol. 2008; 52: 13-16
        • Winkelmayer W.C.
        • Weinstein M.C.
        • Mittleman M.A.
        • Glynn R.J.
        • Pliskin J.S.
        Health economic evaluations: the special case of end-stage renal disease treatment.
        Med Decis Making. 2002; 22: 417-430
        • Lee H.
        • Manns B.
        • Taub K.
        • Ghali W.A.
        • Dean S.
        • Johnson D.
        • et al.
        Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.
        Am J Kidney Dis. 2002; 40: 611-622
        • Laupacis A.
        • Keown P.
        • Pus N.
        • Krueger H.
        • Ferguson B.
        • Wong C.
        • et al.
        A study of the quality of life and cost-utility of renal transplantation.
        Kidney Int. 1996; 50: 235-242
        • Mullins C.D.
        • Thomas S.K.
        • Pradel F.G.
        • Bartlett S.T.
        The economic impact of laparoscopic living-donor nephrectomy on kidney transplantation.
        Transplantation. 2003; 75: 1505-1512
        • Whiting J.F.
        • Kiberd B.
        • Kalo Z.
        • Keown P.
        • Roels L.
        • Kjerulf M.
        Cost-effectiveness of organ donation: evaluating investment into donor action and other donor initiatives.
        Am J Transplant. 2004; 4: 569-573
        • Matas A.J.
        • Schnitzler M.
        Payment for living donor (vendor) kidneys: a cost-effectiveness analysis.
        Am J Transplant. 2004; 4: 216-221
        • Wolfe R.A.
        • Ashby V.B.
        • Milford E.L.
        • Ojo A.O.
        • Ettenger R.E.
        • Agodoa L.Y.
        • et al.
        Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
        N Engl J Med. 1999; 341: 1725-1730
        • Mason H.
        • Jones-Lee M.
        • Donaldson C.
        Modelling the monetary value of a QALY: a new approach based on UK data.
        Health Econ. 2008; (DOI: 10.1002/hec.1416)
        • Laupacis A.
        • Feeny D.
        • Detsky A.S.
        • Tugwell P.X.
        How attractive does a new technology have to be to warrant adoption and utilization?.
        CMAJ. 1992; 146: 473-481
        • McCabe C.
        • Claxton K.
        • Culyer A.J.
        The NICE cost-effectiveness threshold: what it is and what that means.
        Pharmacoeconomics. 2008; 26: 733-744
        • Mendeloff J.
        • Ko K.
        • Roberts M.S.
        • Byrne M.
        • Dew M.A.
        Procuring organ donors as a health investment: how much should we be willing to spend?.
        Transplantation. 2004; 78: 1704-1710
      1. Guidelines for the economic evaluation of health technologies.
        Canadian Agency for Drugs and Technologies in Health, Canada. Ottawa2006
        • van der Mei S.F.
        • Krol B.
        • van Son W.J.
        • de Jong P.E.
        • Groothoff J.
        • van den Heuvel W.J.
        Social participation and employment status after kidney transplantation: a systematic review.
        Qual Life Res. 2006; 15: 979-994
        • Canadian Organ Replacement Register
        Preliminary report for dialysis and transplantation 2008.
        Canadian Institute for Health Information, Ottawa2008
        • Naghibi O.
        • Naghibi M.
        • Nazemian F.
        Factors affecting length of hospitalization in kidney transplant recipients.
        Exp Clin Transplant. 2007; 5: 614-617
        • Smith C.R.
        • Woodward R.S.
        • Cohen D.S.
        • Singer G.G.
        • Brennan D.C.
        • Lowell J.A.
        • et al.
        Cadaveric versus living donor kidney transplantation: a Medicare payment analysis.
        Transplantation. 2000; 69: 311-314
        • Boudville N.
        • Prasad G.V.
        • Knoll G.
        • Muirhead N.
        • Thiessen-Philbrook H.
        • Yang R.C.
        • et al.
        Meta-analysis: risk for hypertension in living kidney donors.
        Ann Intern Med. 2006; 145: 185-196
        • Garg A.X.
        • Muirhead N.
        • Knoll G.
        • Yang R.C.
        • Prasad G.V.
        • Thiessen-Philbrook H.
        • et al.
        Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression.
        Kidney Int. 2006; 70: 1801-1810
        • Gaston R.S.
        • Danovitch G.M.
        • Epstein R.A.
        • Kahn J.P.
        • Matas A.J.
        • Schnitzler M.A.
        Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage.
        Am J Transplant. 2006; 6: 2548-2555
        • Schwartz J.
        • Stegall M.
        • Kremers W.
        • Gloor J.
        Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation.
        Transplantation. 2006; 82: 155-163
        • Segev D.L.
        • Gentry S.E.
        • Warren D.S.
        • Reeb B.
        • Montgomery R.A.
        Kidney paired donation and optimizing the use of live donor organs.
        JAMA. 2005; 293: 1883-1890
        • Roth A.E.
        • Sonmez T.
        • Unver M.U.
        Kidney exchange.
        Q J Economics. 2004; May: 457-488
        • Levy A.R.
        • Sobolev B.
        • James D.
        • Barrable W.
        • Clarke-Richardson P.
        • Sullivan S.D.
        • et al.
        The costs of change: direct medical costs of solid organ transplantation in British Columbia, Canada, 1995-2003.
        Value Health. 2009; 12: 282-292
        • Sheehy E.
        • Conrad S.L.
        • Brigham L.E.
        • Luskin R.
        • Weber P.
        • Eakin M.
        • et al.
        Estimating the number of potential organ donors in the United States.
        N Engl J Med. 2003; 349: 667-674
        • Gill J.
        • Klarenbach S.
        • Cole E.
        • Shemie S.
        Deceased organ donation in Canada: an opportunity to heal a fractured system.
        Am J Transplant. 2008; 8: 1580-1587
        • Roth A.E.
        • Sonmez T.
        • Unver M.U.
        • Delmonico F.L.
        • Saidman S.L.
        Utilizing list exchange and nondirected donation through ‘chain’ paired kidney donations.
        Am J Transplant. 2006; 6: 2694-2705
        • Klarenbach S.
        • Garg A.X.
        • Vlaicu S.
        Living organ donors face financial barriers: a national reimbursement policy is needed.
        CMAJ. 2006; 174: 797-798
        • Israni A.
        • Halpern S.
        • Zink S.
        • Sidhwani S.
        • Caplan A.
        Incentive models to increase living kidney donation: encouraging without coercing.
        Am J Transplant. 2005; 5: 15-20
        • Rodrigue J.R.
        • Cornell D.L.
        • Lin J.K.
        • Kaplan B.
        • Howard R.J.
        Increasing live donor kidney transplantation: a randomized controlled trial of a home-based educational intervention.
        Am J Transplant. 2007; 7: 394-401
        • Miranda B.
        • Vilardell J.
        • Grinyo J.
        Optimizing cadaveric organ procurement: the Catalan and Spanish experience.
        Am J Transplant. 2003; 3: 1189-1196
        • Boulware L.
        • Troll M.
        • Plantinga L.
        • Powe N.
        The association of state and national legislation with living kidney donation rates in the United States: a national study.
        Am J Transplant. 2008; 8: 1451-1470
        • Waterman A.
        • Schenk E.
        • Barrett A.
        • Waterman B.
        • Rodrigue J.
        • Woodle E.
        • et al.
        Incompatible kidney donor candidates' willingness to participate in donor-exchange and non-directed donation.
        Am J Transplant. 2006; 6: 1631-1638
        • Waterman A.D.
        • Brennan D.C.
        Improving patient education delivery to increase living donation rates.
        Am J Transplant. 2007; 7: 269-270
        • Whiting J.F.
        • Woodward R.S.
        • Zavala E.Y.
        • Cohen D.S.
        • Martin J.E.
        • Singer G.G.
        • et al.
        Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments.
        Transplantation. 2000; 70: 755-760
        • Segev D.L.
        • Gentry S.E.
        • Montgomery R.A.
        Association between waiting times for kidney transplantation and rates of live donation.
        Am J Transplant. 2007; 7: 2406-2413